A detailed history of Farallon Capital Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,000 shares of UTHR stock, worth $370,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 143,000 99.3%
Holding current value
$370,830
Previous $45.6 Million 99.21%
% of portfolio
0.0%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $44.2 Million - $51.6 Million
-142,000 Reduced 99.3%
1,000 $358,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $7.53 Million - $10.5 Million
33,000 Added 30.0%
143,000 $45.6 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $77.1 Million - $91.3 Million
-366,000 Reduced 76.89%
110,000 $25.3 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $102 Million - $122 Million
476,000 New
476,000 $105 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $96.7 Million - $110 Million
-471,500 Reduced 70.93%
193,267 $42.7 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $1.89 Million - $2.46 Million
8,894 Added 1.36%
664,767 $149 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $21.9 Million - $29.8 Million
106,200 Added 19.32%
655,873 $182 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $31.9 Million - $38.3 Million
156,977 Added 39.97%
549,673 $115 Million
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $2.27 Million - $3.13 Million
13,000 Added 3.42%
392,696 $92.5 Million
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $9.79 Million - $12.6 Million
58,936 Added 18.37%
379,696 $68.1 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $5.39 Million - $6.32 Million
-29,240 Reduced 8.35%
320,760 $69.3 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $1.39 Million - $1.89 Million
-15,000 Reduced 4.11%
350,000 $42.4 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $29 Million - $42.1 Million
365,000 New
365,000 $34.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.